Growing sudden cardiac arrest incidence is pushing hospitals, outpatient centers, and specialty care facilities to expand point-of-care resuscitation readiness, directly increasing demand for the external defibrillators market. Procurement is increasingly shaped by the need to reduce response time in high-risk areas such as emergency departments, cardiac units, operating rooms, and general wards, where rapid defibrillation can materially affect survival outcomes. This is leading providers to place more automated external defibrillators and advanced external defibrillation systems throughout clinical settings rather than limiting access to critical care zones, encouraging market growth through replacement purchases, broader unit density, and standardized emergency preparedness protocols.
Technological advancements in connected and portable defibrillators strengthening emergency response capabilities
Advances in connectivity, portability, and usability are influencing market adoption in the external defibrillators market by making devices easier to deploy, monitor, and maintain in time-sensitive care environments. Connected defibrillators that support remote status monitoring, readiness checks, and data transfer help healthcare providers and emergency responders reduce downtime linked to expired pads, battery failures, or incomplete maintenance, which directly affects purchasing decisions. At the same time, lighter and more intuitive portable systems improve field mobility for ambulances, clinics, and public responders, reinforcing market demand as buyers prioritize equipment that fits faster intervention workflows and broader distributed placement.
Government-backed public access defibrillator programs expanding AED installations in schools and communities
Public policy support for AED placement is increasing market presence in the external defibrillators market by turning defibrillator access into an organized infrastructure initiative rather than a discretionary purchase. When governments fund or mandate installations in schools, transport hubs, sports venues, and community centers, procurement shifts from isolated institutional buying to larger program-based deployments that often include training, maintenance, and replacement planning. This expands the installed base, normalizes AED presence in non-clinical environments, and strengthens market development by creating recurring demand tied to compliance, operational readiness, and long-term device lifecycle management.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of sudden cardiac arrest increasing deployment of AEDs across healthcare facilities | 2.00% | High | North America, Europe | High | Near Term |
| Technological advancements in connected and portable defibrillators strengthening emergency response capabilities | 1.80% | High | North America, Asia Pacific | High | Mid Term |
| Government-backed public access defibrillator programs expanding AED installations in schools and communities | 1.60% | High | North America, Europe | Medium | Mid Term |
North America held the leading regional position in 2025, accounting for a 45.51% share of the external defibrillators market. This leadership is underpinned by broad device availability across hospitals, emergency medical services, public access locations, and workplace safety programs, which keeps replacement cycles and procurement activity consistently active. The region’s established emergency response infrastructure also supports routine deployment and use of automated external defibrillators, reinforcing demand through practical integration into clinical and non-clinical settings.
Europe is projected to expand at an 11.19% CAGR over the forecast period in the external defibrillators market, driven by wider adoption of public-access defibrillation and stronger integration of these devices into community emergency preparedness efforts. Growth is being accelerated by increased placement across transport hubs, educational institutions, sports facilities, and other public venues where faster bystander response can materially improve outcomes. This is translating into a broader installed base and more consistent purchasing activity across both healthcare and public-use channels.
| Regional Market Attractiveness & Strategic Fit Matrix | |||||
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub | Advanced | Developing | Advanced | Nascent | Nascent |
| Cost-Sensitive Region | Low | Medium | Low | High | High |
| Regulatory Environment | Supportive | Neutral | Restrictive | Neutral | Restrictive |
| Demand Drivers | Strong | Moderate | Strong | Weak | Weak |
| Development Stage | Developed | Developing | Developed | Emerging | Emerging |
| Adoption Rate | High | Medium | High | Low | Low |
| New Entrants / Startups | Dense | Moderate | Dense | Sparse | Sparse |
| Macro Indicators | Strong | Stable | Stable | Weak | Weak |
The U.S. continues to expand external defibrillator deployment across public facilities, workplaces, schools, and healthcare settings to improve emergency cardiac response. Buyers increasingly prioritize connected devices with remote monitoring capabilities, simplified maintenance, and compliance with evolving preparedness programs.
Japan continues to strengthen external defibrillator availability in transportation hubs, educational institutions, and public venues to support rapid intervention. Organizations across Japan increasingly adopt compact, user-friendly systems that enable effective use by both trained responders and the public.
South Korea is incorporating external defibrillators into digitally connected emergency response networks to improve accessibility and readiness. Healthcare providers and public institutions in South Korea prioritize devices with real-time monitoring, automated status reporting, and streamlined maintenance.
Germany emphasizes external defibrillators that deliver dependable performance across hospitals, emergency medical services, and industrial environments. Healthcare providers in Germany favor devices with intuitive operation, standardized maintenance protocols, and integration into established emergency response systems.
France is expanding external defibrillator installations across municipal facilities, commercial buildings, and healthcare institutions to reinforce public safety initiatives. Procurement decisions in France increasingly emphasize operational reliability, regulatory compliance, and ease of deployment across diverse environments.
Italy is increasing the availability of external defibrillators across community locations and healthcare facilities to strengthen emergency preparedness. Organizations in Italy prioritize durable, easy-to-operate systems supported by accessible training and efficient maintenance services.
Within the external defibrillators market, Manual External Defibrillators held a 41.95% share in 2025, reflecting their established role across clinical emergency settings where trained personnel require direct control over rhythm assessment and shock delivery. Their leadership is underpinned by routine use in hospitals and advanced care environments that depend on clinician-led intervention during complex cardiac events. The same operating context also supports continued growth in the external defibrillators market, as healthcare providers prioritize devices that fit established emergency workflows, support rapid decision-making, and remain suitable for high-acuity treatment scenarios where automated alternatives are less preferred.
End-use Segment Analysis: Hospital (Largest Segment) vs Public Access Market (Fastest-Growing Segment)
Hospital accounted for a 28.09% share of the external defibrillators market in 2025, making it the leading end-use segment because defibrillators are integral to emergency departments, intensive care units, operating rooms, and broader inpatient cardiac response systems. Demand remains concentrated in hospitals due to the constant need for immediate resuscitation readiness, the presence of trained staff, and the structured care infrastructure required to support frequent use, maintenance, and integration into acute care protocols.
The Public Access Market is emerging as the fastest-growing end-use segment in the external defibrillators market as defibrillator deployment expands beyond clinical settings into locations where bystander response time can directly affect survival outcomes. Its momentum is underpinned by the practical need to improve access in public spaces, where earlier intervention is critical and where broader installation creates a clearer growth path than in mature hospital environments that already maintain established defibrillator capacity.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| Product | Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators | Manual External Defibrillators | Manual External Defibrillators |
| End-use | Hospital, Pre Hospital, Public Access Market, Alternate Care Market, Home Healthcare | Hospital | Public Access Market |
1. Koninklijke Philips N.V. (Netherlands)
2. Stryker Corporation (United States)
3. ZOLL Medical Corporation (United States)
4. Nihon Kohden Corporation (Japan)
5. Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China)
6. Schiller AG (Switzerland)
7. Mediana Co. Ltd. (South Korea)
8. Corpuls GmbH (Germany)
9. Progetti S.r.l. (Italy)
10. Bexen Cardio S.L. (Spain)
The external defibrillators market is advancing with improved emergency response devices designed to enhance survival outcomes in cardiac events. Integration of smart monitoring and connectivity features is improving device usability in critical situations. The external defibrillators market is also driven by rising awareness of emergency preparedness and public health safety measures.
| Company Name | Date | Key Development |
|---|---|---|
| Philips | Jan-25 | Philips divested its Emergency Care business, including its AED and advanced life-support defibrillator portfolio, to Bridgefield Capital. This significant restructuring of the company’s medical device division includes a long-term brand licensing arrangement, marking a major shift in the competitive landscape and ownership structure of the global defibrillator market. |
| Bridgepoint | Jun-25 | Bridgepoint acquired a controlling interest in Safe Life for approximately €500 million. This investment provides the capital necessary to accelerate the growth of a key provider of defibrillation equipment and emergency training services, signaling continued consolidation and increased investment activity within the external defibrillator market ecosystem. |
| Safe Life | Jul-25 | Safe Life acquired Salvavidas Cardio to bolster its emergency response product portfolio and expand its geographic footprint. The transaction enhances the company's capabilities in the distribution and service of automated external defibrillator solutions, strengthening its competitive positioning and operational scale within the lifesaving equipment sector. |
| Stryker | Sep-25 | Stryker inaugurated a new 140,000-square-foot R&D facility in Bengaluru, India. The site features advanced laboratories dedicated to the development of next-generation healthcare technologies, including automated external defibrillators. This expansion strengthens Stryker's global innovation pipeline and reinforces its operational commitment to developing and commercializing localized medical device solutions. |
| Avive Solutions | Sep-25 | Avive Solutions received regulatory approval for the Avive Connect AED for in-flight use. As one of the most compact and lightweight devices available, it supports specialized emergency response in aviation environments. The device integrates remote monitoring and real-time data reporting capabilities, expanding the utility of AEDs into mobile and high-demand transport settings. |
| Avive Solutions | Oct-24 | Avive Solutions launched the QuickRescue feature for the Avive Connect AED, developed in partnership with RapidSOS. The technology transmits real-time incident data, including patient status and precise location, directly to 911 dispatchers. This advancement in digital connectivity improves emergency response coordination and enhances clinical outcomes for out-of-hospital cardiac arrests. |
As of 2026 the market size of external defibrillators is valued at USD 4.49 billion.
External Defibrillators Market size is likely to expand from USD 4.13 billion in 2025 to USD 10.62 billion by 2035 posting a CAGR above 9.9% across 2026-2035.
Healthcare providers are expanding AED deployment beyond critical care areas to improve response times, increase point-of-care readiness, and standardize emergency preparedness, supporting broader procurement, replacement purchases, and higher device density across clinical settings.
Connected defibrillators improve readiness through remote monitoring and simplified maintenance, while government-backed public access programs drive large-scale installations with recurring demand for training, maintenance, compliance, and device replacement.
Manual External Defibrillators held a 41.95% market share in 2025 because hospitals and advanced care settings rely on trained clinicians for direct rhythm assessment, controlled shock delivery, and integration into established emergency response workflows.
The Public Access Market is growing fastest as defibrillators are increasingly installed in public locations to enable earlier bystander intervention, improving access where rapid response can significantly influence survival outcomes.
North America’s 45.51% share is driven by widespread hospital and EMS deployment, public access availability, strong emergency response systems, and consistent procurement and replacement cycles.
Europe’s 11.19% CAGR is supported by expanding public-access defibrillation, installations across transport hubs, schools, and sports facilities, and stronger community emergency preparedness initiatives.
Major players in the external defibrillators market include Koninklijke Philips N.V. (Netherlands), Stryker Corporation (United States), ZOLL Medical Corporation (United States), Nihon Kohden Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Schiller AG (Switzerland), Mediana Co., Ltd. (South Korea), Corpuls GmbH (Germany), Progetti S.r.l. (Italy), Bexen Cardio S.L. (Spain).